ClinConnect ClinConnect Logo
Search / Trial NCT06192355

Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.

Launched by UNIVERSITY HOSPITAL AUGSBURG · Dec 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Endoscopy Emergency

ClinConnect Summary

This clinical trial is looking at two types of gastroscopes—one-time use and reusable—used in patients who have upper gastrointestinal bleeding, which means bleeding in the stomach or the part of the intestine closest to the stomach. The goal is to see if one type of scope works better than the other for diagnosing and treating this condition.

To take part in the study, participants must be between the ages of 65 and 74 and show certain signs of bleeding that are serious enough to need medical attention. They should have a specific score on a test that helps doctors determine the severity of their condition. However, pregnant individuals and those who cannot give consent will not be able to join. If you participate, you can expect to have either a single-use or a reusable gastroscope used during your procedure, and the study will help researchers understand which option may be more effective for patients in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Glasgow-Blatchford score (GBS) \>2
  • Clinical signs of upper bleeding
  • Exclusion Criteria:
  • pregnancy
  • Unable to provide consent

About University Hospital Augsburg

University Hospital Augsburg is a leading academic medical center located in Augsburg, Germany, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between multidisciplinary teams of researchers, clinicians, and patients. With a commitment to enhancing patient outcomes and contributing to the global medical community, University Hospital Augsburg emphasizes ethical standards, patient safety, and the development of novel therapeutic approaches in various fields of medicine.

Locations

Augsburg, Bavaria, Germany

Patients applied

0 patients applied

Trial Officials

Christoph Römmele, MD

Principal Investigator

Unervsity Hospital Augsburg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported